G2GBIO Inc. (KOSDAQ:456160)
103,100
-2,400 (-2.27%)
At close: Feb 26, 2026
G2GBIO Market Cap
G2GBIO has a market cap or net worth of 1.78 trillion as of February 27, 2026.
Market Cap
1.78T
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
103,100.00
Market Cap Chart
Since August 14, 2025, G2GBIO's market cap has increased from 503.30B to 1.78T, an increase of 253.01%. That is a compound annual growth rate of 934.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 1.78T | 61.49% |
| Dec 30, 2025 | 1.10T | 118.59% |
| Aug 14, 2025 | 503.30B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Myung In Pharmaceutical LTD. | 966.52B |
| Samyang Biopharm | 722.02B |
| ImmuneOncia Therapeutics | 620.76B |
| HEM Pharma | 573.02B |
| CellBion | 355.43B |
| DAE HWA Pharmaceutical | 291.48B |
| NOVAREX | 244.82B |
| OPTUS Pharmaceutical | 207.88B |